Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease

This publication has 18 references indexed in Scilit:

• Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide
  European Heart Journal, 2004
• Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
  New England Journal of Medicine, 2004
• Immunoluminometric Assay for the Midregion of Pro-Atrial Natriuretic Peptide in Human Plasma
  Clinical Chemistry, 2004
• Atrial Natriuretic Peptide Prohormone Gene Expression: Hormones and Diseases That Upregulate its Expression
  IUBMB Life, 2002
• The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes
  New England Journal of Medicine, 2001
• Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction
  International Journal of Cardiology, 1998
• Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.
  Heart, 1995
• N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.
  Circulation, 1994
• Transient myocardial ischemia stimulates atrial natriuretic factor release
  American Heart Journal, 1992
• Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
  Journal of the American Society of Echocardiography, 1989